Home | News | Find a Doctor | Ask a Question | Free

Now that ICX has made fools of all of you


#1

And basically confirmed I was right all along

its funny how really only one guy came out and had the guts to say, Hangin was right all along

Its also amazing how the delusional ones still refuse to face the truth and read what ICX has on their website as what it is…

As I said before, you guys , some of you, are delusional. You believe what you want to believe. You would be perfect marks for a ponzi scheme setup by a financial schemer because you do not judge things with a critical eye.

You guys all along said, Hangin you are too negative you do not want HM to come to reality you are a pessimist why are you on this board . I said no, i would love for HM to become reality, however I do not see results coming out of ICX that make me feel comfortable, and there is not yet concrete proof at this point, so I reserve judgement for when they have a product they want to bring to market. Still this attitude was crucified on the board, by the delusional ones.

Now ICX has made a fool of all of you. And validated my healthy skepticism. But most of you , are not even man enough to admit I was right , and apologize.

I didnt expect as much though. Your wounded pride is taking a beating today


#2

I still say you’re full of bull, Hangin.

Yesterday I was trying to talk you down from the idea that the ICX hairs woudln’t even be DHT resistant.

This ICX update doesn’t disappoint me at all. I’m actually a little encouraged.

It’s called realistic expectations. Being realistic includes the possibility of changes in the operation & timeframe before it reaches the market.

The only thing I’ve ever wanted/expected from ICX right now is some assurances that the basic technology is progressing. It needs to look like it’ll probably work well, feasibly, and safely. I think we’ve got even more evidence now that it will.


#3

» I still say you’re full of bull, Hangin.
»
» Yesterday I was trying to talk you down from the idea that the ICX hairs
» woudln’t even be DHT resistant.
»
»
»
» This ICX update doesn’t disappoint me at all. I’m actually a little
» encouraged.
»
» It’s called realistic expectations. Being realistic includes the
» possibility of changes in the operation & timeframe before it reaches the
» market.
»
» The only thing I’ve ever wanted/expected from ICX right now is some
» assurances that the basic technology is progressing. It needs to look
» like it’ll probably work well, feasibly, and safely. I think we’ve got
» even more evidence now that it will.

you just proved you are one of the delusional ones

hey i have this deal where a guy from nigeria will wire 25 million into your account you can keep 7 million, Interested?

guys like you also make perfect candidates for cults, you do not ask logical questions, you distort reality so that things appear as you wish they were instead of how they really are

how guys like you get through life without being run over by an 18 wheeler is a mystery to me


#4

Intercytex is far from “shutting down’ ICX-TRC. Intrecytex is shutting down ICX-TRC as much as it is shutting down its promising ICX-SKN cell therapy, which if you read the same announcement, is also intended to be offered to a partner to commercialise the product after Phase II results become available. This is the same as what is happening with ICX-TRC, offering to a partner to continue clinical and commercial development after finalisation of Phase II trials. It is not surprising at all that a small company like Intercytex is courting larger partners to commercialise its discoveries. From what I can gather, Interctex has gone it alone on the commercialisation of Vavelta. However, the acquisition of cells, processing and delivery of cells for an allogeneic cell therapy (ie Vavelta) is far less complex and far less expensive than the acquisition, processing and delivery of cells for an autologous cell therapy (ie ICX-TRC). A small company in development, like Intercytex, can only take on so much at any one time. It is surprising that a small company like Intercytex undertook the commercialisation of Vavelta on its own. It is not at all surprising, regardless of how “good” interim Phase II results may be, that Intercytex is pulling in larger financial partners for the commercialisation and distribution of ICX-TRC.


#5

i think it looks like small scale commercialisation like they said before

its same with vavelta, only specialist can give to customers


#6

» » I still say you’re full of bull, Hangin.
» »
» » Yesterday I was trying to talk you down from the idea that the ICX
» hairs
» » woudln’t even be DHT resistant.
» »
» »
» »
» » This ICX update doesn’t disappoint me at all. I’m actually a little
» » encouraged.
» »
» » It’s called realistic expectations. Being realistic includes the
» » possibility of changes in the operation & timeframe before it reaches
» the
» » market.
» »
» » The only thing I’ve ever wanted/expected from ICX right now is some
» » assurances that the basic technology is progressing. It needs to look
» » like it’ll probably work well, feasibly, and safely. I think we’ve got
» » even more evidence now that it will.
»
» you just proved you are one of the delusional ones
»
» hey i have this deal where a guy from nigeria will wire 25 million into
» your account you can keep 7 million, Interested?
»
» guys like you also make perfect candidates for cults, you do not ask
» logical questions, you distort reality so that things appear as you wish
» they were instead of how they really are
»
» how guys like you get through life without being run over by an 18 wheeler
» is a mystery to me

Why do you think you some how know more than everyone else, If someone doesn’t see something the same way as you they are delusional?
You are not some hair loss God, that knows all and can see into the future.

Can you even say for definate that TRC is over? no you can’t? you just have an opinion!

were you expecting people to look in this thread and go " oh Hanging were so sorry, you were right all along" if that is the case then you are a fool.

If ICX said they are releasing tomorrow would you have made a thread saying “sorry guys I was wrong”? no I don’t think so either.

It is highly doubtful that ICX looking for a partner is “spin” they are looking for help from a larger more established company, thats it.

Also there is no evidence to suggest TRC has been canned YET I’m fully aware that this can happen, but they haven’t even said as much, all they have said is their not going to commence phase III or commercialization without the aid of another company.

Before you say I’m also delusional or overly optimistic, I am not, I can just look on the both sides, unlike you who is always negative.

This post Is not an angry one, I know it might seem like it and I’m not trying to be personal.
You were obviously trying to provoke people with this post anyway.
Its just your high and mighty attitude that you know everything about HM astonishes me, you are the one that can’t see things from a different perspective!
This is a HM board, where people are supposed to come and discuss HM from BOTH angles weather it be pessimistic or optimistic, everyone including you has a right to their opinion, including you.
You just shouldn’t try and force it on others or shutdown others for believing in something else.

Also the childishness of some of your posts is incredible for someone who obviously thinks so highly of Himself, sometimes it seems you are incapable of an intelligent adult conversation with the way you respond.

edit
Got beaten to it!


#7

» Intercytex is far from “shutting down’ ICX-TRC. Intrecytex is shutting
» down ICX-TRC as much as it is shutting down its promising ICX-SKN cell
» therapy, which if you read the same announcement, is also intended to be
» offered to a partner to commercialise the product after Phase II results
» become available. This is the same as what is happening with ICX-TRC,
» offering to a partner to continue clinical and commercial development
» after finalisation of Phase II trials. It is not surprising at all that a
» small company like Intercytex is courting larger partners to commercialise
» its discoveries. From what I can gather, Interctex has gone it alone on
» the commercialisation of Vavelta. However, the acquisition of cells,
» processing and delivery of cells for an allogeneic cell therapy (ie
» Vavelta) is far less complex and far less expensive than the acquisition,
» processing and delivery of cells for an autologous cell therapy (ie
» ICX-TRC). A small company in development, like Intercytex, can only take
» on so much at any one time. It is surprising that a small company like
» Intercytex undertook the commercialisation of Vavelta on its own. It is
» not at all surprising, regardless of how “good” interim Phase II results
» may be, that Intercytex is pulling in larger financial partners for the
» commercialisation and distribution of ICX-TRC.

why is it important for us to know their funding? its not. If the results were promising, funding would not be an issue, remember this is a publicly traded company , they could issue more stock I would think.

Why would they put on their website we do not intend to fund further research etc…


#8

when i post about HM i am not negative, i am skeptical, have always been, and have been called a troublemaker for it

you are not delusional? the company just came out and said they will not continue to fund trials. If the results were promising , they WOULD CONTINUE TO FUND TRIALS

they KNOW how much phase three costs, and have always known this. It is not a secret. If the problem was , that they had no money for phase three trials, this also would have been known to them all along, they did not all of the sudden discover they cannot afford phase three and needed a partner. That is what stockholders are PARTNERS, they invest in companies so that the company can afford to expand, and if the company is successful the stockholders get paid back through dividends or increased stock price.

This we need a partner is total bs.


#9

» when i post about HM i am not negative, i am skeptical, have always been,
» and have been called a troublemaker for it
»
» you are not delusional? the company just came out and said they will not
» continue to fund trials. If the results were promising , they WOULD
» CONTINUE TO FUND TRIALS
»
» they KNOW how much phase three costs, and have always known this. It is
» not a secret. If the problem was , that they had no money for phase three
» trials, this also would have been known to them all along, they did not
» all of the sudden discover they cannot afford phase three and needed a
» partner. That is what stockholders are PARTNERS, they invest in companies
» so that the company can afford to expand, and if the company is successful
» the stockholders get paid back through dividends or increased stock price.
»
»
» This we need a partner is total bs,

You have obviously been called a trouble maker for provoking people all the time.

you can see what I think about TRC in the ‘high dose results are worse than low dose thread’. If you still want to call me delusional fine then if thats what you think it obviously must be true.

All you have done is further confirm everything I have said in my previous post.

“the company just came out and said they will not continue to fund trials. If the results were promising , they WOULD CONTINUE TO FUND TRIALS”

No they said they wouldn’t fund phase III or commercialization unless they get a partner. If they get a partner there will probably be phase III.

“they KNOW how much phase three costs, and have always known this. It is
not a secret. If the problem was , that they had no money for phase three
trials, this also would have been known to them all along, they did not
all of the sudden discover they cannot afford phase three and needed a
partner.”

I wasn’t aware that there was a set price for a phase III trial, maybe you can enlighten me?
Companies make losses, ICX made quite a big loss last year, subsequently this could leave them with very little money to continue with another trial…they are running out of money!
They could very well have only recently realized that they are going to need more money for phase III, of course this is just a guess, how do you know they would have known all along. Thats like saying this time next year I’m going to be a millionaire, or next year I’m going to be broke.
They could have come across some unexpected setbacks, it could have cost more than they thought? we will never know.

“That is what stockholders are PARTNERS, they invest in companies
so that the company can afford to expand, and if the company is successful
the stockholders get paid back through dividends or increased stock price.”

Yes your right, but what if these companies that initially invested find out that ICX is losing more money than it can make? they could refuse to invest more and demand to start seeing some return! which inturn would force ICX too look elsewhere !

This is just a guess off course and the fact of the matter is neither of us know the truth.


#10

» » »
» why is it important for us to know their funding? its not. If the results
» were promising, funding would not be an issue, remember this is a publicly
» traded company , they could issue more stock I would think.
»
» Why would they put on their website we do not intend to fund further
» research etc…
»
» again you are another one of the delusional ones who refuse to face the
» truth

It is important to know ICX’s funding arrangements. History’s dustbins are littered with great scientific discoveries and advancements which went nowhere due to lack of funding. Many have waited in the ether until their “rediscovery” many years down the track. Just because something works or is an advancement doesn’t always mean that it will attract the funding it deserves (eg research Kroto (Univ. of Sussex) Carbon 60 mid 1980’s).

For a publicly traded company, just issuing stock to raise funds for the commercialisation of a product is not always in the best interest of existing shareholders. Issuing stock dilutes a company’s equity, and dilutes any returns from a commercialisation. A partnership may yield better share holder value than issuing stock, if structured correctly.

Personally, I believe Intercytex has chosen not to fund the continuation of clinical and commercial development of ICX-TRC and ICX-SKN beyond Phase II due to a lack of resources. The company has net assets of $13m pounds, which classifies it as a financial minnow. Perhaps the company’s directors have come to the conclusion that there is better shareholder value in funding the commercialisation of ICX-TRC and ICX-SKN through partnership rather than through the dilution of stock.


#11

You clearly do not understand how companies work, nor do you understand cash flow.

Bottom line: if there are good results, ICX will have a partner before the end of the year. In fact, it’s probably the best scenario to have a partner like Bosley.

The good news is that when someone comes out with a viable solution, you’ll start seeing many other solutions come to market…

» And basically confirmed I was right all along
»
» its funny how really only one guy came out and had the guts to say, Hangin
» was right all along
»
» Its also amazing how the delusional ones still refuse to face the truth
» and read what ICX has on their website as what it is…
»
»
»
»
» As I said before, you guys , some of you, are delusional. You believe what
» you want to believe. You would be perfect marks for a ponzi scheme setup by
» a financial schemer because you do not judge things with a critical eye.
»
» You guys all along said, Hangin you are too negative you do not want HM to
» come to reality you are a pessimist why are you on this board . I said no,
» i would love for HM to become reality, however I do not see results coming
» out of ICX that make me feel comfortable, and there is not yet concrete
» proof at this point, so I reserve judgement for when they have a product
» they want to bring to market. Still this attitude was crucified on the
» board, by the delusional ones.
»
» Now ICX has made a fool of all of you. And validated my healthy
» skepticism. But most of you , are not even man enough to admit I was right
» , and apologize.
»
» I didnt expect as much though. Your wounded pride is taking a beating
» today


#12

» » when i post about HM i am not negative, i am skeptical, have always
» been,
» » and have been called a troublemaker for it
» »
» » you are not delusional? the company just came out and said they will
» not
» » continue to fund trials. If the results were promising , they WOULD
» » CONTINUE TO FUND TRIALS
» »
» » they KNOW how much phase three costs, and have always known this. It is
» » not a secret. If the problem was , that they had no money for phase
» three
» » trials, this also would have been known to them all along, they did not
» » all of the sudden discover they cannot afford phase three and needed a
» » partner. That is what stockholders are PARTNERS, they invest in
» companies
» » so that the company can afford to expand, and if the company is
» successful
» » the stockholders get paid back through dividends or increased stock
» price.
» »
» »
» » This we need a partner is total bs, designed to pull the wool over the
» » eyes of uneducated gullible guys, who basically are the same ones who
» » swallowed their story all along. that would include you.
»
» You have obviously been called a trouble maker for provoking people all
» the time.
»
» you can see what I think about TRC in the ‘high dose results are worse
» than low dose thread’. If you still want to call me delusional fine then
» if thats what you think it obviously must be true.
»
» All you have done is further confirm everything I have said in my previous
» post.
»
» “the company just came out and said they will not continue to fund trials.
» If the results were promising , they WOULD CONTINUE TO FUND TRIALS”
»
» No they said they wouldn’t fund phase III or commercialization unless they
» get a partner. If they get a partner there will probably be phase III.
»
»
» “they KNOW how much phase three costs, and have always known this. It is
» not a secret. If the problem was , that they had no money for phase three
» trials, this also would have been known to them all along, they did not
» all of the sudden discover they cannot afford phase three and needed a
» partner.”
»
» I wasn’t aware that there was a set price for a phase III trial, maybe you
» can enlighten me?
» Companies make losses, ICX made quite a big loss last year, subsequently
» this could leave them with very little money to continue with another
» trial…they are running out of money!
» They could very well have only recently realized that they are going to
» need more money for phase III, of course this is just a guess, how do you
» know they would have known all along. Thats like saying this time next
» year I’m going to be a millionaire, or next year I’m going to be broke.
» They could have come across some unexpected setbacks, it could have cost
» more than they thought? we will never know.
»
»
» “That is what stockholders are PARTNERS, they invest in companies
» so that the company can afford to expand, and if the company is
» successful
» the stockholders get paid back through dividends or increased stock
» price.”
»
» Yes your right, but what if these companies that initially invested find
» out that ICX is losing more money than it can make? they could refuse to
» invest more and demand to start seeing some return! which inturn would
» force ICX too look elsewhere !
» This is just a guess off course and the fact of the matter is neither
» of us know the truth
.

They probably have this agenda for a long time like I said before. The phases swallows so much money and they knew that the Intercytex´s own money resources are never enough. It must be hard to develope so many inventions in the same time. They thought (long time ago) that they will surely need more money when the phase II enter. How come this is hard to belive?

They gave the option to Bosley because maybe Bosley was the only one who take the risk then in the early stages. Bosley has option, but the partner could be some other company as well. It´s the Bosley who have permission to say yes or no first. Bosley is NOT the partner yet.

Why the yesterday news/announcement is so short concerning TRC, that´s bad thing.

My Dream


#13

» You clearly do not understand how companies work, nor do you understand
» cash flow.
»
» Bottom line: if there are good results, ICX will have a partner before the
» end of the year. In fact, it’s probably the best scenario to have a partner
» like Bosley.

I’ve kept out of this but just to say you are right. In the biotech industry virtually NO company will push past phaseII alone. PhaseII is proof of concept in the clinic and the value is ramped. If things look good then the attrition rate at phase III is less than 30% and in this case it is more likely to be less than 5%. All the same who knows, none of what has been said gives an idea of how well the product is working.

The one thing that does spring to mind is that a partner company may want the “best” product in place before phaseIII since the same trial would need to be run again even if there is a small change in protocol and that’s not cheap!!!


#14

nt


#15

Ok first of all hanging is an idiot and thats the problem everybody has with him.He is the same idiot as nathan and the game they only difference is that they are on opposite sides.Noone could safely predict the future of TRC, not even the developers of the technology.

But its obvious now that the project cannot be financed and everything will stop unless somebody buys the technology WITH THE INTENTION TO SEEK FDA APPROVAL :slight_smile:

Its obvious that the results though encouraging regarding new hair appearing… are at the same time not impressive to develop a product since the same or even better results can be achieved by propecia or minoxidil

The hint regarding the results not beiing good were in the prestimulation strategies that intercytex decided to adopt :).right there and then we should all understand that something is wrong and the product cannot stand on its own.Stimulating the scalp alone(more blood flow as an example) can have limited regrowth effect so we dont even know what percentage of growth was because of pre-stim and because of the product.

The news are definetely very bad and anyone with a brain should be able to see it and we should not be dellusional.

Never the less this should be a lesson to all to not put their hopes on experimental techniques and dream of release dates.The product even if it comes to the market by some company its obvious that it is very far from beiing what we thought it is…


#16

Hangininthere, to be honest If ICX did outright say that TRC was a failure and the project is being ditched then I would have said fair play, you where right, and if that day does come then that is what I will say to you.

But that is just still not the position we are in at the moment.


#17

if results r bad then why not cancel phase ii cinlical and commercial programme now why carry on until end ??? why is commercial work going on with trc if there is nothing to commercialise ? why look for partner,

how can results be bad when they say they have positive data and then they say limitless hair can be made


#18

Great post TheOne, it exactly describes Hanging as he is, just the exact opposite of the Game and Nathan. Hanging always takes everything Intercytex says and puts the biggest negative spin on it, while Nathan and the Game put the most positive spin on it. The difference between these two parties is Hanging is by far the most annoying posting 100 times a day to beat his point into you. These constant posts are not filled with constructive critism but calling people names because they challenge his illogical thought to the point of calling them bald on a Hairloss site. This is one place most of us seek refuge from being called bald, while this guy balding himself makes fun of others balding because they don’t believe in his negative thought. Your a pathetic piece of work Hanging. I think out of all the people on this forum your actually happy for Intercytex’s stumbles, as it some twisted way supposedly validates what you have predictied for the longest time. Hanging I say this with the greatest sincerity get a life man.


#19

Predicting that any new medical technology will fail to address a stubborn, age-old problem that has eluded serious researchers – and “winning” that bet – is nothing to crow about. It’s not evidence of sage wisdom or well-informed research or superior knowledge. Statistically, it’s a slam-dunk. It’s the safest bet in the world, and only one a benighted idiot would avail himself of in order to brag about “winning” – as tho it was somehow indicative of a rare gift of insight that distinguished him from others. There were any number of well-researched cancer therapies introduced with great hope into trials in recent years – specifically one for pancreatic cancer and another for metastatic breast cancer. Both of those, we now know, turned out to be total failures and have been pulled from trials. So, you might want to boldly predict the failure of the rest of them, too, in order to assign yourself the “winner” status you apparently desperately need. Because the fact is, overwhelmingly, MOST new efforts at therapy for complex, longstanding diseases don’t work. That’s why they’re still diseases. So betting against such attempts – whether it’s hair loss or cancer – and gleefully saying “I told you so” to the ones who had hoped for a positive outcome, is no accomplishment and nothing to your credit. It’s just the feeble attempt of a small mind to inflate a sagging ego.


#20

I was not betting against ICX i just simply said that you guys are jumping the gun, and trying to theorize the release dates cost etc

for this I was crucified